These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance. Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651 [TBL] [Abstract][Full Text] [Related]
47. Experimental Determination and Theoretical Calculation of the Eutectic Composition of Cefuroxime Axetil Diastereomers. Dalal N; Buckner IS; Wildfong PLD AAPS PharmSciTech; 2017 Oct; 18(7):2570-2578. PubMed ID: 28229357 [TBL] [Abstract][Full Text] [Related]
48. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614 [TBL] [Abstract][Full Text] [Related]
49. Direct measurement of molecular mobility and crystallisation of amorphous pharmaceuticals using terahertz spectroscopy. Sibik J; Zeitler JA Adv Drug Deliv Rev; 2016 May; 100():147-57. PubMed ID: 26772139 [TBL] [Abstract][Full Text] [Related]
50. Nose Temperature and Anticorrelation between Recrystallization Kinetics and Molecular Relaxation Dynamics in Amorphous Morniflumate at High Pressure. Romanini M; Rodriguez S; Valenti S; Barrio M; Tamarit JL; Macovez R Mol Pharm; 2019 Aug; 16(8):3514-3523. PubMed ID: 31274326 [TBL] [Abstract][Full Text] [Related]
51. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems. Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500 [TBL] [Abstract][Full Text] [Related]
52. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin. Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228 [TBL] [Abstract][Full Text] [Related]
54. Design of Ternary Amorphous Solid Dispersions for Enhanced Dissolution of Drug Combinations. Li J; Duggirala NK; Kumar NSK; Su Y; Suryanarayanan R Mol Pharm; 2022 Aug; 19(8):2950-2961. PubMed ID: 35797094 [TBL] [Abstract][Full Text] [Related]
55. Molecular Dynamics and Physical Stability of Ibuprofen in Binary Mixtures with an Acetylated Derivative of Maltose. Grzybowska K; Grzybowski A; Knapik-Kowalczuk J; Chmiel K; Woyna-Orlewicz K; Szafraniec-Szczęsny J; Antosik-Rogóż A; Jachowicz R; Kowalska-Szojda K; Lodowski P; Paluch M Mol Pharm; 2020 Aug; 17(8):3087-3105. PubMed ID: 32584584 [TBL] [Abstract][Full Text] [Related]
56. Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure. Law D; Wang W; Schmitt EA; Qiu Y; Krill SL; Fort JJ J Pharm Sci; 2003 Mar; 92(3):505-15. PubMed ID: 12587112 [TBL] [Abstract][Full Text] [Related]
57. Aging of the Johari-Goldstein relaxation in the glass-forming liquids sorbitol and xylitol. Yardimci H; Leheny RL J Chem Phys; 2006 Jun; 124(21):214503. PubMed ID: 16774419 [TBL] [Abstract][Full Text] [Related]
58. Coupling between chemical reactivity and structural relaxation in pharmaceutical glasses. Shamblin SL; Hancock BC; Pikal MJ Pharm Res; 2006 Oct; 23(10):2254-68. PubMed ID: 16941232 [TBL] [Abstract][Full Text] [Related]
59. The glass transition and dielectric secondary relaxation of fructose-water mixtures. Shinyashiki N; Shinohara M; Iwata Y; Goto T; Oyama M; Suzuki S; Yamamoto W; Yagihara S; Inoue T; Oyaizu S; Yamamoto S; Ngai KL; Capaccioli S J Phys Chem B; 2008 Dec; 112(48):15470-7. PubMed ID: 18991437 [TBL] [Abstract][Full Text] [Related]
60. Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives. Li Z; Lee PI Int J Pharm; 2016 May; 505(1-2):283-8. PubMed ID: 27079143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]